Science
Mechanism of Action
Tetrandrine operates as a calcium channel blocker, modulating calcium influx essential for various cellular functions. It exhibits anti-inflammatory effects by inhibiting mast cell degranulation and suppressing the NF-κB pathway, thereby reducing pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8. Additionally, it demonstrates anti-fibrogenic actions by inhibiting fibroblast activation, reducing collagen production, and decreasing pro-fibrotic cytokines like TGF-β. In inflammatory skin contexts, it can promote the expansion of regulatory T cells (CD4+Foxp3+ Tregs) via the TNF-TNFR2 pathway.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 In vitro, Tetrandrine (4 µM) demonstrated antiproliferative activity against human A673 cells.
- 02 In vitro, Tetrandrine (15.8 µM) showed antiproliferative activity against vincristine-resistant human CEM cells.
- 03 In vitro, Tetrandrine (5 µM) induced autophagy in HeLa, MCF-7, and human foreskin fibroblast (HFF) cells.
- 04 In vitro, Tetrandrine (5 and 10 µM) pre-treatment of mesenchymal stem cells (MSCs) significantly reduced TNF-α secretion by RAW 264.7 cells in co-culture.
- 05 In vitro, Tetrandrine inhibited the growth of human skin fibroblasts in a dose- and time-dependent manner.
- 06 Topical application of Tetrandrine nanoemulsion in mice promoted CD4+Foxp3+ regulatory T cell expansion and alleviated imiquimod-induced psoriasis.
Transparency
Dusting Analysis
Tetrandrine is not commonly found or marketed in consumer skincare products; its primary application is within scientific research for its diverse biological activities.
The Formula
Formulation
Stability
Tetrandrine exhibits poor aqueous solubility, dissolving better in alcohols, ether, and chloroform. Its low water solubility and bioavailability often necessitate advanced nanocarrier delivery systems (e.g., liposomes, microspheres, nanoparticles) for enhanced stability and efficacy in formulations.
Safety
Safety Profile
Tetrandrine is listed in FDA GSRS and EPA DSSTox, but lacks specific cosmetic safety assessments by CIR or SCCS. General GHS classification indicates 'Danger: Fatal if swallowed' (Acute Tox. 2) and 'Harmful if swallowed' (Acute Tox. 4) for oral routes. Its usage is generally restricted to 'For research use only. We do not sell to patients.'
Your Skin
Skin Compatibility
Our Assessment
Verdict
While demonstrating potent biological activities in vitro and in animal models, the absence of cosmetic-specific safety data and severe oral toxicity warnings make Tetrandrine an unsuitable ingredient for topical skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources